Your browser doesn't support javascript.
loading
Stochastic Epigenetic Mutations Are Associated with Risk of Breast Cancer, Lung Cancer, and Mature B-cell Neoplasms.
Gagliardi, Amedeo; Dugué, Pierre-Antoine; Nøst, Therese H; Southey, Melissa C; Buchanan, Daniel D; Schmidt, Daniel F; Makalic, Enes; Hodge, Allison M; English, Dallas R; Doo, Nicole W; Hopper, John L; Severi, Gianluca; Baglietto, Laura; Naccarati, Alessio; Tarallo, Sonia; Pace, Luigia; Krogh, Vittorio; Palli, Domenico; Panico, Salvatore; Sacerdote, Carlotta; Tumino, Rosario; Lund, Eiliv; Giles, Graham G; Pardini, Barbara; Sandanger, Torkjel M; Milne, Roger L; Vineis, Paolo; Polidoro, Silvia; Fiorito, Giovanni.
Afiliação
  • Gagliardi A; Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Torino, Italy. gagliardi.borsisti@iigm.it.
  • Dugué PA; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Nøst TH; Cancer Epidemiology Division, Cancer Council of Victoria, Melbourne, Victoria, Australia.
  • Southey MC; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Buchanan DD; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Schmidt DF; Department of Community Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
  • Makalic E; Cancer Epidemiology Division, Cancer Council of Victoria, Melbourne, Victoria, Australia.
  • Hodge AM; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • English DR; Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • Doo NW; Department of Clinical Pathology | Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne Centre for Cancer Research Level 10, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.
  • Hopper JL; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Severi G; Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.
  • Baglietto L; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Naccarati A; Cancer Epidemiology Division, Cancer Council of Victoria, Melbourne, Victoria, Australia.
  • Tarallo S; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Pace L; Cancer Epidemiology Division, Cancer Council of Victoria, Melbourne, Victoria, Australia.
  • Krogh V; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Palli D; Cancer Epidemiology Division, Cancer Council of Victoria, Melbourne, Victoria, Australia.
  • Panico S; Concord Repatriation General Hospital, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Sacerdote C; Concord Clinical School, University of Sydney, Concord, New South Wales, Australia.
  • Tumino R; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Lund E; Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Université Paris-Saclay, UPS, USQ, Gustave Roussy, Villejuif, France.
  • Giles GG; Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Université Paris-Saclay, UPS, USQ, Gustave Roussy, Villejuif, France.
  • Pardini B; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Sandanger TM; Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Torino, Italy.
  • Milne RL; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Vineis P; Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Torino, Italy.
  • Polidoro S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Fiorito G; Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Candiolo, Torino, Italy.
Cancer Epidemiol Biomarkers Prev ; 29(10): 2026-2037, 2020 10.
Article em En | MEDLINE | ID: mdl-32788174

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfoma Difuso de Grandes Células B / Epigênese Genética / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Screening_studies / Systematic_reviews Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfoma Difuso de Grandes Células B / Epigênese Genética / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Screening_studies / Systematic_reviews Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália